S100A11 and nasopharyngeal carcinoma: Additionally, immunohistochemistry revealed decreased expression of Ki-67 and S100A11 in the tumors (Fig. 7D), confirming the potential of hsa_circ_0000105 as a therapeutic target in NPC.